Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Theodore S Johnson

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Immunological Investigations|September 29, 2012
Host indoleamine 2,3-dioxygenase: contribution to systemic acquired tumor toleranceTheodore S Johnson, David H Munn
Advances in Experimental Medicine and Biology|December 25, 2017
Chemo-Immunotherapy: Role of Indoleamine 2,3-Dioxygenase in Defining Immunogenic Versus Tolerogenic Cell Death in the Tumor MicroenvironmentTheodore S Johnson, Tracy Mcgaha, David H Munn
Cancer Research|September 6, 2018
Treg Destabilization and Reprogramming: Implications for Cancer ImmunotherapyDavid H Munn, Madhav D Sharma, Theodore S Johnson
Clinical & Developmental Immunology|February 8, 2012
Modulation of tumor tolerance in primary central nervous system malignanciesTheodore S Johnson, David H Munn, Bernard L Maria
Cancer Immunology, Immunotherapy : CII|May 11, 2017
IDO, PTEN-expressing Tregs and control of antigen-presentation in the murine tumor microenvironmentDavid H Munn, Madhav D Sharma, Theodore S Johnson, et al.
Journal of Immunological Methods|November 30, 2010
Contemporary diagnostic methods for hemophagocytic lymphohistiocytic disordersTheodore S Johnson, Joyce Villanueva, Alexandra H Filipovich, et al.
Pediatric Transplantation|March 22, 2017
TFE3-positive renal cell carcinoma occurring in three children with dysfunctional kidneys on immunosuppressionBeverly A Schaefer, Theodore S Johnson, David K Hooper, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 22, 2013
Etoposide selectively ablates activated T cells to control the immunoregulatory disorder hemophagocytic lymphohistiocytosisTheodore S Johnson, Catherine E Terrell, Scott H Millen, et al.
Molecular Cancer Therapeutics|December 23, 2024
Blocking Feedback Immunosuppression of Antigen Presentation in Brain Tumor During Oncolytic Virotherapy with oHSV-mshPKRNobushige Tsuboi, Kimberly A Rivera-Caraballo, Upasana Sahu, et al.
Biorxiv : the Preprint Server for Biology|June 12, 2026
BTK inhibition enhances immunovirotherapy in glioblastoma via tertiary lymphoid structure modulationKonstantina Kyritsi, Dong Zhu, Haocheng Ding, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Immunological Investigations|September 29, 2012
Host indoleamine 2,3-dioxygenase: contribution to systemic acquired tumor toleranceTheodore S Johnson, David H Munn
Advances in Experimental Medicine and Biology|December 25, 2017
Chemo-Immunotherapy: Role of Indoleamine 2,3-Dioxygenase in Defining Immunogenic Versus Tolerogenic Cell Death in the Tumor MicroenvironmentTheodore S Johnson, Tracy Mcgaha, David H Munn
Cancer Research|September 6, 2018
Treg Destabilization and Reprogramming: Implications for Cancer ImmunotherapyDavid H Munn, Madhav D Sharma, Theodore S Johnson
Clinical & Developmental Immunology|February 8, 2012
Modulation of tumor tolerance in primary central nervous system malignanciesTheodore S Johnson, David H Munn, Bernard L Maria
Cancer Immunology, Immunotherapy : CII|May 11, 2017
IDO, PTEN-expressing Tregs and control of antigen-presentation in the murine tumor microenvironmentDavid H Munn, Madhav D Sharma, Theodore S Johnson, et al.
Journal of Immunological Methods|November 30, 2010
Contemporary diagnostic methods for hemophagocytic lymphohistiocytic disordersTheodore S Johnson, Joyce Villanueva, Alexandra H Filipovich, et al.
Pediatric Transplantation|March 22, 2017
TFE3-positive renal cell carcinoma occurring in three children with dysfunctional kidneys on immunosuppressionBeverly A Schaefer, Theodore S Johnson, David K Hooper, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 22, 2013
Etoposide selectively ablates activated T cells to control the immunoregulatory disorder hemophagocytic lymphohistiocytosisTheodore S Johnson, Catherine E Terrell, Scott H Millen, et al.
Molecular Cancer Therapeutics|December 23, 2024
Blocking Feedback Immunosuppression of Antigen Presentation in Brain Tumor During Oncolytic Virotherapy with oHSV-mshPKRNobushige Tsuboi, Kimberly A Rivera-Caraballo, Upasana Sahu, et al.
Biorxiv : the Preprint Server for Biology|June 12, 2026
BTK inhibition enhances immunovirotherapy in glioblastoma via tertiary lymphoid structure modulationKonstantina Kyritsi, Dong Zhu, Haocheng Ding, et al.
Pageof 2